4.8 Article

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

Laurent Mailly et al.

NATURE BIOTECHNOLOGY (2015)

Article Gastroenterology & Hepatology

Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection

Francois Habersetzer et al.

LIVER INTERNATIONAL (2015)

Article Pharmacology & Pharmacy

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

Matthieu Blanchet et al.

ANTIVIRAL RESEARCH (2014)

Article Biochemistry & Molecular Biology

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP

Masashi Iwamoto et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Review Gastroenterology & Hepatology

Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes

Stephan Urban et al.

GASTROENTEROLOGY (2014)

Review Biochemistry & Molecular Biology

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry

Koichi Watashi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Medicine, General & Internal

Hepatitis B virus infection

Christian Trepo et al.

LANCET (2014)

Article Gastroenterology & Hepatology

Chronic hepatitis D at a standstill: where do we go from here?

Alessia Ciancio et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Article Virology

Entry of hepatitis B and C viruses - recent progress and future impact

Thomas F. Baumert et al.

CURRENT OPINION IN VIROLOGY (2014)

Article Multidisciplinary Sciences

Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors

Oscar Lamas Longarela et al.

PLOS ONE (2013)

Review Gastroenterology & Hepatology

The Molecular Virology of Hepatitis B Virus

Dieter Glebe et al.

SEMINARS IN LIVER DISEASE (2013)

Review Infectious Diseases

Selection of chronic hepatitis B therapy with high barrier to resistance

Robert Gish et al.

LANCET INFECTIOUS DISEASES (2012)

Review Gastroenterology & Hepatology

Virology of Hepatitis D Virus

John M. Taylor

SEMINARS IN LIVER DISEASE (2012)

Review Oncology

Glypican-3: A new target for cancer immunotherapy

Mitchell Ho et al.

EUROPEAN JOURNAL OF CANCER (2011)

Article Genetics & Heredity

Common variation in GPC5 is associated with acquired nephrotic syndrome

Koji Okamoto et al.

NATURE GENETICS (2011)

Article Biochemistry & Molecular Biology

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger et al.

NATURE MEDICINE (2011)

Article Medicine, General & Internal

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

Heiner Wedemeyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Biotechnology & Applied Microbiology

Glypicans

Jorge Filmus et al.

GENOME BIOLOGY (2008)

Review Multidisciplinary Sciences

Heparan sulphate proteoglycans fine-tune mammalian physiology

Joseph R. Bishop et al.

NATURE (2007)

Article Oncology

Role for amplification and expression of Glypican-5 in rhabdomyosarcoma

Daniel Williamson et al.

CANCER RESEARCH (2007)

Article Biochemistry & Molecular Biology

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

H Barth et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Review Biochemistry & Molecular Biology

The role of glypicans in mammalian development

HH Song et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)

Article Multidisciplinary Sciences

Infection of a human hepatoma cell line by hepatitis B virus

P Gripon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)